645 Phase I study of adoptive T cell therapy following HER2-pulsed dendritic cell vaccine and pepinemab/trastuzumab in patients with metastatic HER2-positive breast cancer (MBC)
暂无分享，去创建一个
B. Czerniecki | F. Locke | L. Loftus | R. Costa | A. Soyano | H. Khong | H. Soliman | E. Evans | M. Zauderer | A. Armaghani | Kimberley T. Lee | Hien D. Liu | T. Fisher | H. Han | L. Karyampudi | Alexandria M Shrewsbury | Jessica Malka